See the DrugPatentWatch profile for Menactra
What is Menactra, and what does it protect against?
Menactra is a vaccine that helps protect against meningococcal disease caused by certain types of Neisseria meningitidis (meningococcus). It targets meningococcal serogroups A, C, W, and Y.
Who is Menactra for (age and dosing)?
Menactra is given to children and adolescents and is also used for certain older people who are at increased risk for meningococcal disease. The exact schedule depends on the person’s age and health or risk factors (for example, if someone has conditions that increase the risk of invasive meningococcal disease).
How many doses are needed, and when are they given?
The dose schedule depends on the age at first vaccination. People who start vaccination at younger ages typically need a multi-dose schedule, while those who start at older ages may receive fewer doses.
What side effects do people report after Menactra?
Common side effects after Menactra are usually mild and short-lived and can include pain, redness, or swelling at the injection site, fever, headache, and fatigue. More serious allergic reactions are rare but are a key safety concern with any vaccine.
How effective is Menactra?
Menactra works by training the immune system to recognize meningococcal A, C, W, and Y. Like other vaccines, its effectiveness is measured by the immune response it produces (antibody responses) and by observed protection against disease in the populations studied.
Who should not get Menactra, or should talk to a clinician first?
People should not receive Menactra if they have had a serious allergic reaction to a prior dose of the vaccine or to any component of the vaccine. Anyone with a significant current illness or specific immune system concerns should discuss timing and suitability with a clinician.
Can Menactra be given with other vaccines?
In typical practice, Menactra can often be given around the same time as other recommended vaccines, but the exact co-administration schedule depends on age and the vaccines being planned. Clinicians commonly give vaccines at different injection sites when needed.
What’s the difference between Menactra and other meningococcal vaccines?
“Meningococcal vaccine” can refer to different products with different serogroup coverage and different schedules. Menactra covers A, C, W, and Y. Other meningococcal vaccines may cover additional or different serogroups and may be used based on age, risk, and local recommendations.
How do people who are traveling or in dorms typically handle meningococcal vaccination?
People at increased risk—such as college students living in dormitories, military recruits, travelers to areas with outbreaks, or those with certain medical conditions—may be recommended to get meningococcal vaccination. Whether Menactra alone is sufficient depends on the specific risk profile and which meningococcal vaccines are recommended in their setting.
Menactra safety and pregnancy: what should people know?
For people who are pregnant, vaccination decisions are usually made case-by-case based on risk of exposure and vaccine recommendations. If you tell me the age and situation (routine schedule, travel, dorm, medical condition, pregnancy), I can help narrow down what Menactra is typically used for and what questions to ask a clinician.
Sources
I don’t have the provided reference materials needed to cite specific details about Menactra’s schedule, age indications, or safety statements from your dataset. If you share the allowed source text/links, I can produce a fully cited, precise answer.